Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

32.7K
Overview
32.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

86
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
86
Cross-reactivity00:42

Cross-reactivity

33.4K
Overview
33.4K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
Antibody Structure01:10

Antibody Structure

66.3K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
66.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discrimination of crystal polymorphism in active pharmaceutical ingredients using time-domain <sup>1</sup>H NMR relaxation combined with multivariate statistical process control.

International journal of pharmaceutics·2026
Same author

Half-release and full aspiration technique for endoscopic ultrasound-guided hepaticogastrostomy in severe acute cholangitis.

Endoscopy·2026
Same author

A Rare but Life-Threatening Complication of Direct Endoscopic Necrosectomy: Tension Pneumoperitoneum With Pneumothorax and Hypercapnia due to Walled-Off Necrosis Rupture.

Case reports in gastrointestinal medicine·2026
Same author

Rescue multihole metal stent placement to prevent stent migration after endoscopic ultrasound-guided hepaticogastrostomy.

Endoscopy·2026
Same author

Is Thymic Involution Truly a Deterioration or an Adaptation?

Bulletin of mathematical biology·2026
Same author

Human papillomavirus driving cervical cancer: A mathematical model with persistent infection, cancer progression, and spontaneous remission.

Journal of theoretical biology·2025

Related Experiment Video

Updated: Mar 2, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.7K

When is allergen immunotherapy effective?

Akane Hara1, Yoh Iwasa2

  • 1Department of Biology, Faculty of Science, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan .

Journal of Theoretical Biology
|May 10, 2017
PubMed
Summary
This summary is machine-generated.

Allergen immunotherapy for Japanese cedar pollen allergy (JCPA) can be effective by modulating T helper 2 (Th2) and regulatory T cells (Treg). Mathematical modeling identified optimal conditions for successful therapy, emphasizing linear dose increases for better resistance.

Keywords:
Dynamical modelRegulatory T cellsTh2 cells

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.0K

Related Experiment Videos

Last Updated: Mar 2, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

9.7K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

3.1K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

4.0K

Area of Science:

  • Immunology
  • Computational Biology
  • Allergy Research

Background:

  • Allergen immunotherapy (AIT) aims to suppress allergic rhinitis and ocular symptoms in Japanese cedar pollen allergy (JCPA) patients.
  • Current AIT involves prolonged administration of small allergen doses to induce tolerance.
  • Understanding the immunological dynamics is crucial for optimizing AIT efficacy.

Purpose of the Study:

  • To develop a mathematical model to predict effective conditions for allergen immunotherapy.
  • To identify key immunological parameters influencing therapeutic success in JCPA.
  • To evaluate the impact of different dosing strategies on treatment outcomes.

Main Methods:

  • A simple mathematical model was constructed to simulate T helper 2 (Th2) and regulatory T cell (Treg) dynamics.
  • Model parameters were analyzed to define conditions for successful therapy, including symptom prevention and avoiding therapy-induced allergies.
  • The model incorporated cell differentiation from naive T cells and differential cell lifespans.

Main Results:

  • Therapeutic success was defined by symptom absence during environmental exposure and lack of allergic reaction to therapy.
  • Specific parameter ranges were identified where AIT is likely to be successful.
  • Linear dose increases in therapy promoted Treg accumulation and enhanced resistance compared to constant doses, reducing allergy risk.

Conclusions:

  • Mathematical modeling provides a framework for understanding and optimizing allergen immunotherapy for JCPA.
  • The longer lifespan of Treg cells is key to accumulating long-term resistance.
  • Linear dose escalation strategies appear more effective and safer for inducing sustained tolerance.